Liposuction News
-
Cryoliposculpt by Biotec Italia, the scientifically proven evolution of traditional Cryolipolysis
A valid alternative to liposuction is represented by Cryolipolysis, a non-invasive Aesthetic Medicine technique for body contouring. The Biotec Italia Medical team has patented Cryoliposculpt, an innovative device that stands out from other technologies on the market. This is a true evolution of cryolipolysis procedures, as also demonstrated by numerous scientific articles written on ...
-
InGeneron Publishes Significant Support for the Existence of Naturally Pluripotent Stem Cells in All Organs in the Adult Body
InGeneron, Inc., a clinical stage regenerative medicine and cell therapy company, announced the publication of the first comprehensive analysis providing significant support for the existence of naturally pluripotent stem cells in all organs. Pluripotent stem cells have the ability to become any cell type of the adult body. The newly-released publication, entitled “Perspective: Why and How ...
-
Tissue Genesis` Icellator X Delivers Results in First Clinical Application
Tissue Genesis, a leading developer of cell therapy processing systems, announced today that an initial group of patients was successfully treated in the first clinical application of its Icellator® X technology at the Okyanos Center for Regenerative Medicine in Freeport, Bahamas. The new fully enclosed and automated system generated a higher yield of stem cells from adipose (fat) tissue than ...
-
InGeneron Initiates Pivotal Study for its Clinical Lead Program in Rotator Cuff Tendinopathy
InGeneron, Inc., a regenerative medicine and cell therapy company, announced today the enrollment of the first patients in a pivotal study evaluating InGeneron’s cell therapy as a way to treat partial thickness rotator cuff tears involving a partial tear in the supraspinatus tendon. The primary goal of the double-blinded, multi-center trial is to demonstrate the effectiveness of the ...
-
USRM Chief Science Officer to Present at Fifth Annual Cell Surgical World Conference
U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, will be presenting at the Fifth Annual Cell Surgical World Conference in Beverly Hills this Saturday, June 2. Dr. Comella is, to the Company’s best knowledge, one of the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you